Increased Levels of NF-κB Inhibitors (IκBα and IκBγ) in the Intestinal Mucosa of Crohn's Disease Patients during Infliximab Treatment.

Autor: Guidi, L., Costanzo, M., Ciarniello, M., De Vitis, I., Pioli, C., Gatta, L., Pace, L., Tricerri, A., Bartoloni, C., Coppola, L., Balistreri, P., Doria, G., Fedeli, G., Gasbarrini, G.B.
Zdroj: International Journal of Immunopathology & Pharmacology; Jan-Mar2005, Vol. 18 Issue 1, p155-164, 10p
Databáze: Complementary Index